Position in IQV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$20,276,313
-$1,966,025 QoQ
Shares Held
104,939
-19.5% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
1.73%
of 13F equity value
Holder Rank
#147
of 1,077 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 46%
Shared 0%
None 54%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Clarkston Capital Partners, LLC holds $24,794,095 across 3 Diagnostics & Research names. IQV ranks #1 (81.8% of the industry book) .
All Filings in IQV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,276,313 | 104,939 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $22,242,338 | 130,423 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $56,921,660 | 252,525 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $49,759,531 | 261,975 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $41,284,640 | 261,975 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,231,200 | 24,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,716,240 | 24,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,554,550 | 15,000 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,960,160 | 14,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,540,460 | 14,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,619,660 | 7,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||